HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xueliang Fan Selected Research

Glutamate Receptors (Glutamate Receptor)

3/2012Selective and sustained α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor activation in cerebellum induces dystonia in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xueliang Fan Research Topics

Disease

10Dystonia (Limb Dystonia)
01/2021 - 01/2006
3Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2012 - 04/2007
2Dystonic Disorders (Writer's Cramp)
01/2021 - 10/2015
2Dystonia musculorum deformans type 1
01/2019 - 10/2012
2Coloboma (Colobomas)
01/2010 - 04/2007
1Dopa-responsive Dystonia
01/2021
1Parkinsonian Disorders (Parkinsonism)
12/2017
1Dyskinesias (Dyskinesia)
10/2015
1Type 2 Episodic Ataxia
11/2014
1Ataxia (Dyssynergia)
11/2014
1Parkinson Disease (Parkinson's Disease)
07/2014
1Atrophy
10/2012
1Paroxysmal nonkinesigenic dyskinesia
02/2012

Drug/Important Bio-Agent (IBA)

11Dopamine (Intropin)FDA LinkGeneric
01/2021 - 04/2007
3Dopamine Receptors (Dopamine Receptor)IBA
01/2018 - 04/2007
3Dopamine Agonists (Dopamine Agonist)IBA
01/2018 - 10/2015
3Amphetamine (Amfetamine)FDA LinkGeneric
10/2012 - 04/2007
2Neurotransmitter Agents (Neurotransmitter)IBA
01/2021 - 01/2012
2Trihexyphenidyl (Artane)FDA LinkGeneric
01/2019 - 10/2015
2Levodopa (L Dopa)FDA LinkGeneric
12/2017 - 10/2015
2Dopamine AntagonistsIBA
10/2015 - 04/2007
1Proteins (Proteins, Gene)FDA Link
01/2021
1Dihydroxyphenylalanine (Dopa)IBA
01/2019
1Pharmaceutical PreparationsIBA
01/2019
1Cholinesterase Inhibitors (Anticholinesterases)IBA
01/2019
1Cholinergic Agents (Cholinergics)IBA
01/2019
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
01/2019
1Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
01/2019
1Dopamine Agents (Dopaminergic Agents)IBA
01/2018
1Ethanol (Ethyl Alcohol)IBA
11/2014
1Caffeine (No Doz)FDA LinkGeneric
11/2014
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
07/2014
1Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA
07/2014
1Codon (Codons)IBA
10/2012
1Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
10/2012
1Glutamic Acid (Glutamate)FDA Link
03/2012
1Glutamate Receptors (Glutamate Receptor)IBA
03/2012
1AMPA Receptors (AMPA Receptor)IBA
03/2012
1AcidsIBA
03/2012
1PicrotoxinIBA
03/2012
1Serotonin (5 Hydroxytryptamine)IBA
01/2012
1Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2012
1Kainic Acid (Kainate)IBA
09/2008
1Calcium Channels (Calcium Channel)IBA
09/2008
1SCH 23390IBA
04/2007
1Haloperidol (Haldol)FDA LinkGeneric
04/2007
1RacloprideIBA
04/2007
1L-Type Calcium Channels (Dihydropyridine Receptor)IBA
01/2006

Therapy/Procedure

2Therapeutics
01/2010 - 04/2007